ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001

Shubik Subcommittee Fails To Agree On Draft Document

February 13, 1976

Policy Of 5,000 Grants Meant As Floor, Not Ceiling, Former White House Advisor Insists

March 8, 1985

Duke Insiders Allege Intimidation By Administration

July 23, 2010